These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sensitized Lyt-2+ T cells trigger rejection of grafts expressing class I major histocompatibility complex alloantigens. Warren HS; Simeonovic CJ; Dixon JE; Pembrey RG; Lafferty KJ Transplant Proc; 1986 Apr; 18(2):310-2. PubMed ID: 3083544 [No Abstract] [Full Text] [Related]
3. An attempt at an interpretation of the mouse H-2 complex. Klein J Contemp Top Immunobiol; 1976; 5():297-336. PubMed ID: 61100 [No Abstract] [Full Text] [Related]
4. Collaboration between in vivo responses to LD and SD antigens of major histocompatibility complex. Sollinger HW; Bach FH Nature; 1976 Feb; 259(5543):487-8. PubMed ID: 130556 [No Abstract] [Full Text] [Related]
5. The use of H-2 mutants as models for the study of T cell activation. McKenzie IF; Pang T; Blanden RV Immunol Rev; 1977; 35():179-230. PubMed ID: 70397 [No Abstract] [Full Text] [Related]
6. Recent advances in the understanding of rejection. Hamburger J Adv Nephrol Necker Hosp; 1975; 5():101-14. PubMed ID: 127520 [No Abstract] [Full Text] [Related]
7. The H(Tla) histocompatibility locus: a study of in vitro lymphocyte reactivity. Widmer MB; Schendel DJ; Bach FH; Boyse EA Transplant Proc; 1973 Dec; 5(4):1663-7. PubMed ID: 4130073 [No Abstract] [Full Text] [Related]
8. Testing immunological responses to experimental allografts. Hamburger J; Debray-Sachs M; Dimitriu A; Dy M; Caraux J Transplant Proc; 1974 Dec; 6(4 Suppl 1):85-91. PubMed ID: 4280168 [No Abstract] [Full Text] [Related]
9. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells. Kedar E; Bonavida B J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487 [No Abstract] [Full Text] [Related]
10. Use of genetically defined nude mice in the study of the mixed leukocyte reaction. Croy BA; Osoba D J Immunol; 1974 Nov; 113(5):1626-34. PubMed ID: 4278870 [No Abstract] [Full Text] [Related]
12. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity. Rouse BT; Wagner H J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454 [No Abstract] [Full Text] [Related]
13. On the relationship between initiator and effector cells in the response to major tansplantation antigens. Howard JC Transplant Proc; 1973 Dec; 5(4):1451-6. PubMed ID: 4130057 [No Abstract] [Full Text] [Related]
14. Cellular immunogenetics of HLA: quantitative crossmatches for LD and CD determinants. Bach FH Transplant Proc; 1978 Mar; 10(1):63-6. PubMed ID: 76353 [No Abstract] [Full Text] [Related]
16. Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice. Isakov N; Bach FH J Immunol; 1985 Jun; 134(6):3580-5. PubMed ID: 2859332 [TBL] [Abstract][Full Text] [Related]
17. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections. Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561 [No Abstract] [Full Text] [Related]
18. Correlation between cellular manifestations of allograft response and graft rejection times. Viklický V; Polácková M Folia Biol (Praha); 1974; 20(2):125-32. PubMed ID: 4140110 [No Abstract] [Full Text] [Related]
20. Genetic and cellular control of in vitro models of allograft reactivity. Bach FH; Alter BJ; Schendel DJ; Segall M; Bach ML Birth Defects Orig Artic Ser; 1975; 11(1):467-76. PubMed ID: 238687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]